Abdulkadir Mohammed Danyaro, Habibu Tijjani, Swinder Jeet Singh Kalra & Ahmed Olatunde. 2023. Parasitic Infections. Parasitic Infections
303
327
.
Qwait AlGabbani. (2023) Nanotechnology: A promising strategy for the control of parasitic infections. Experimental Parasitology 250, pages 108548.
Crossref
Charmante Registre, Rodrigo D. O. A. Soares, Karina T. S. Rubio, Orlando D. H. Santos & Simone P. Carneiro. (2023) A Systematic Review of Drug-Carrying Nanosystems Used in the Treatment of Leishmaniasis. ACS Infectious Diseases 9:3, pages 423-449.
Crossref
Janani Vassoudevane, Monika Mariebernard & Vinoth Rajendran. (2023) Stearylamine Liposome as an Anti-Parasitic Agent. Drugs and Drug Candidates 2:1, pages 95-108.
Crossref
Prakash Kumar, Pawan Kumar, Nidhi Singh, Salil Khajuria, Rahul Patel, Vinod Kumar Rajana, Debabrata Mandal & Ravichandiran Velayutham. (2022) Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Hammad Ur Rehman Bajwa, Muhammad Kasib Khan, Zaheer Abbas, Roshan Riaz, Tauseef ur Rehman, Rao Zahid Abbas, Muhammad Tahir Aleem, Asghar Abbas, Mashal M. Almutairi, Fahdah Ayed Alshammari, Yasser Alraey & Abdulaziz Alouffi. (2022) Nanoparticles: Synthesis and Their Role as Potential Drug Candidates for the Treatment of Parasitic Diseases. Life 12:5, pages 750.
Crossref
Sriram Kannan, Yifat Harel, Liron Limor Israel, Emmanuel Lellouche, Alexander Varvak, Merav Nadav Tsubery, Jean-Paul Lellouche & Shulamit Michaeli. (2021) Novel Nanocarrier Platform for Effective Treatment of Visceral Leishmaniasis. Bioconjugate Chemistry 32:11, pages 2327-2341.
Crossref
Devika M. Varma, Elizabeth A. Redding, Eric M. Bachelder & Kristy M. Ainslie. (2020) Nano- and Microformulations to Advance Therapies for Visceral Leishmaniasis. ACS Biomaterials Science & Engineering 7:5, pages 1725-1741.
Crossref
Sapna Jain Chowdhary, Amit Chowdhary, Govind Prasad Agrawal & Ashish Jain. (2020) A Formulation of Paromomycin Sulphate as a Promising Fucose-Conjugated Nanostructured Lipid Carrier for Antileishmanial Drug Delivery. ACS Biomaterials Science & Engineering 7:1, pages 157-165.
Crossref
Giuliana Muraca, Ignacio Rivero Berti, María L. Sbaraglini, Wagner J. Fávaro, Nelson Durán, Guillermo R. Castro & Alan Talevi. (2020) Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers. Frontiers in Chemistry 8.
Crossref
Mohammad Imani & Azam Dehghan. 2020. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment
295
357
.
Pankaj Kumar Singh, Bapi Gorain, Hira Choudhury, Sachin Kumar Singh, Pankaj Whadwa, Shilpa, Sanjeev Sahu, Monica Gulati & Prashant Kesharwani. (2020) Macrophage targeted amphotericin B nanodelivery systems against visceral leishmaniasis. Materials Science and Engineering: B 258, pages 114571.
Crossref
Alessandra Castegna, Rosanna Gissi, Alessio Menga, Monica Montopoli, Maria Favia, Antonella Viola & Marcella Canton. (2020) Pharmacological targets of metabolism in disease: Opportunities from macrophages. Pharmacology & Therapeutics 210, pages 107521.
Crossref
Kenward Vong, Katsunori Tanaka & Koichi Fukase. 2020. Handbook of In Vivo Chemistry in Mice. Handbook of In Vivo Chemistry in Mice
489
529
.
Frances K. Nally, Chiara De Santi & Claire E. McCoy. (2019) Nanomodulation of Macrophages in Multiple Sclerosis. Cells 8:6, pages 543.
Crossref
Mehran Alavi & Mehrdad Hamidi. (2019) Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metabolism and Personalized Therapy 34:1.
Crossref
Vandana Soni, Silki Chandel, Vikas Pandey, Saket Asati, Priyanka Jain, Aviral Jain & Rakesh K. Tekade. 2019. Biomaterials and Bionanotechnology. Biomaterials and Bionanotechnology
263
300
.
Priyanka Jahagirdar, Amit S. Lokhande, Prajakta Dandekar & Padma V. Devarajan. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
433
456
.
Rohan Ghadi & Neha Dand. (2017) BCS class IV drugs: Highly notorious candidates for formulation development. Journal of Controlled Release 248, pages 71-95.
Crossref
Swati Pund & Amita Joshi. 2017. Nano- and Microscale Drug Delivery Systems. Nano- and Microscale Drug Delivery Systems
439
480
.
N. Škalko-Basnet & Ž. Vanić. 2017. Functionalized Nanomaterials for the Management of Microbial Infection. Functionalized Nanomaterials for the Management of Microbial Infection
111
152
.
Yihua Pei & Yoon Yeo. (2016) Drug delivery to macrophages: Challenges and opportunities. Journal of Controlled Release 240, pages 202-211.
Crossref
Shigeru Kawakami & Mitsuru Hashida. (2014) Glycosylation-mediated targeting of carriers. Journal of Controlled Release 190, pages 542-555.
Crossref
Prasad V. Pawar, Abraham J. Domb & Neeraj Kumar. 2014. Focal Controlled Drug Delivery. Focal Controlled Drug Delivery
61
91
.